Found 4 matching trials
A Study of MM-111 in Combination With Multiple Treatments in Patients With HER2 Positive Cancer PHASE1 This study is an open-label, dose-escalation study of MM-111 with five diff...
Show More Location
Rocky Mountain Cancer Centers
Learn More & Join Trial
A Study of MM-111 in Patients With Advanced, Refractory Her2 Amplified, Heregulin Positive Cancers PHASE1 This study is an open-label Phase 1 trial of MM-111....
Location
University of Southern California Norris Comprehensive Cancer Center
Learn More & Join Trial
MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer PHASE1 This is an open-label Phase 1 trial of MM-111 in combination with Herceptin...
Show More Location
Indiana University (IUPUI)
Learn More & Join Trial
A Study of MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach PHASE2 To determine whether the combination of MM-111 plus paclitaxel and trastuzu...
Show More Location
Multiple Locations
Learn More & Join Trial